Zajicek JP[au] - Search Results

Year	Number of Results
1992	1
1994	1
1997	1
1999	1
2000	1
2001	1
2004	3
2005	3
2006	1
2007	1
2008	2
2009	1
2010	2
2011	10
2012	8
2013	3
2014	1
2016	2
2017	1
2018	1
2022	0

1

Neurosarcoidosis.

Zajicek JP. Zajicek JP. Curr Opin Neurol. 2000 Jun;13(3):323-5. doi: 10.1097/00019052-200006000-00016. Curr Opin Neurol. 2000. PMID: 10871259 Review.

2

Role of cannabinoids in multiple sclerosis.

Zajicek JP, Apostu VI. Zajicek JP, et al. CNS Drugs. 2011 Mar;25(3):187-201. doi: 10.2165/11539000-000000000-00000. CNS Drugs. 2011. PMID: 21323391 Review.

3

Designing clinical trials in older people.

Carroll CB, Zajicek JP. Carroll CB, et al. Among authors: zajicek jp. Maturitas. 2011 Apr;68(4):337-41. doi: 10.1016/j.maturitas.2011.02.002. Epub 2011 Mar 3. Maturitas. 2011. PMID: 21376485 Review.

4

The pathogenesis of demyelinating disease.

Scolding NJ, Zajicek JP, Wood N, Compston DA. Scolding NJ, et al. Among authors: zajicek jp. Prog Neurobiol. 1994 Jun;43(2):143-73. doi: 10.1016/0301-0082(94)90011-6. Prog Neurobiol. 1994. PMID: 7972853 Review. No abstract available.

5

A systematic review of biomarkers for disease progression in Parkinson's disease.

McGhee DJ, Royle PL, Thompson PA, Wright DE, Zajicek JP, Counsell CE. McGhee DJ, et al. Among authors: zajicek jp. BMC Neurol. 2013 Apr 12;13:35. doi: 10.1186/1471-2377-13-35. BMC Neurol. 2013. PMID: 23587062 Free PMC article. Review.

6

A systematic review of biomarkers for disease progression in Alzheimer's disease.

McGhee DJ, Ritchie CW, Thompson PA, Wright DE, Zajicek JP, Counsell CE. McGhee DJ, et al. Among authors: zajicek jp. PLoS One. 2014 Feb 18;9(2):e88854. doi: 10.1371/journal.pone.0088854. eCollection 2014. PLoS One. 2014. PMID: 24558437 Free PMC article. Review.

7

Therapeutic potential of cannabis in pain medicine.

Hosking RD, Zajicek JP. Hosking RD, et al. Among authors: zajicek jp. Br J Anaesth. 2008 Jul;101(1):59-68. doi: 10.1093/bja/aen119. Epub 2008 May 29. Br J Anaesth. 2008. PMID: 18515270 Free article. Review.

8

The use of decision-analytic models in Parkinson's disease: a systematic review and critical appraisal.

Shearer J, Green C, Counsell CE, Zajicek JP. Shearer J, et al. Among authors: zajicek jp. Appl Health Econ Health Policy. 2011 Jul 1;9(4):243-58. doi: 10.2165/11590160-000000000-00000. Appl Health Econ Health Policy. 2011. PMID: 21682352 Review.

9

Rating scales as outcome measures for clinical trials in neurology: problems, solutions, and recommendations.

Hobart JC, Cano SJ, Zajicek JP, Thompson AJ. Hobart JC, et al. Among authors: zajicek jp. Lancet Neurol. 2007 Dec;6(12):1094-105. doi: 10.1016/S1474-4422(07)70290-9. Lancet Neurol. 2007. PMID: 18031706 Review.

10

Model-based economic evaluation in Alzheimer's disease: a review of the methods available to model Alzheimer's disease progression.

Green C, Shearer J, Ritchie CW, Zajicek JP. Green C, et al. Among authors: zajicek jp. Value Health. 2011 Jul-Aug;14(5):621-30. doi: 10.1016/j.jval.2010.12.008. Value Health. 2011. PMID: 21839398 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results